Insider Trading History of Yancopoulos George

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Yancopoulos George since 2005. This trader's CIK number is 1226690. At the time of last reporting, Yancopoulos George was the Bd. Co-Chair, President & CSO of Regeneron Pharmaceuticals, Inc.. (stock ticker symbol REGN). Also see all insider trading activities at Regeneron Pharmaceuticals, Inc..



Yearly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN) by Yancopoulos George

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 REGN 0 $0 33,696 $30,326,400 172,723 $69,030,474
2023 REGN 0 $0 16,845 $13,492,724 25,155 $0
2021 REGN 0 $0 180,000 $104,329,267 442,267 $99,412,776
2020 REGN 0 $0 235,938 $105,438,820 644,815 $28,269,573
2019 REGN 0 $0 0 $0 245,295 $5,212,518
2018 REGN 0 $0 0 $0 244,048 $4,100,006
2017 REGN 0 $0 0 $0 195,438 $4,284,000
2016 REGN 0 $0 0 $0 195,079 $3,964,005
2015 REGN 0 $0 86,696 $48,552,013 184,739 $2,227,950
2014 REGN 0 $0 88,987 $28,744,936 198,447 $3,695,832
2013 REGN 0 $0 100,000 $26,288,000 206,612 $5,099,948
2012 REGN 0 $0 94,028 $10,070,677 194,547 $3,056,086
2011 REGN 0 $0 27,713 $1,639,362 200,000 $5,602,000
2009 REGN 0 $0 0 $0 100,000 $877,000
2008 REGN 0 $0 26,991 $442,652 100,000 $741,000
2007 REGN 0 $0 40,839 $996,746 100,000 $1,056,299
2006 REGN 0 $0 900 $15,512 0 $0
2005 REGN 0 $0 5,500 $81,801 25,000 $318,750


Insider trading of Regeneron Pharmaceuticals, Inc. (REGN) by Yancopoulos George

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-01-02 REGN Sale 16,848 900.00 15,163,200
2024-02-15 REGN Option Ex 172,723 399.66 69,030,474
2024-01-02 REGN Sale 16,848 900.00 15,163,200
2023-12-11 REGN Option Ex 25,155 .00 0
2023-03-23 REGN Sale 3,656 804.29 2,940,469
2023-02-06 REGN Sale 13,189 800.08 10,552,255
2021-12-22 REGN Option Ex 442,267 224.78 99,412,776
2021-08-13 REGN Sale 773 625.00 483,125
2021-08-16 REGN Sale 49,227 625.67 30,800,103
2021-08-05 REGN Sale 50,000 600.06 30,002,999
2021-06-21 REGN Sale 80,000 538.04 43,043,040
2020-12-30 REGN Option Ex 398,079 52.03 20,712,050
2020-03-10 REGN Sale 117,815 473.68 55,807,080
2020-03-09 REGN Option Ex 246,736 30.63 7,557,523
2020-02-24 REGN Sale 118,123 420.17 49,631,740
2019-12-12 REGN Option Ex 245,295 21.25 5,212,518
2018-12-13 REGN Option Ex 244,048 16.80 4,100,006
2017-12-13 REGN Option Ex 195,438 21.92 4,284,000
2016-12-15 REGN Option Ex 195,079 20.32 3,964,005
2015-12-16 REGN Option Ex 1,921 52.03 99,949
2015-12-02 REGN Sale 43,348 548.99 23,797,401
2015-10-30 REGN Option Ex 182,818 11.64 2,128,001
2015-11-02 REGN Sale 43,348 571.07 24,754,612
2014-12-16 REGN Option Ex 3,264 30.63 99,976
2014-08-27 REGN Option Ex 5,720 314.31 1,797,853
2014-02-12 REGN Sale 88,987 323.02 28,744,936
2014-02-11 REGN Option Ex 189,463 9.49 1,798,003
2013-12-19 REGN Option Ex 4,705 21.25 99,981
2013-12-12 REGN Option Ex 9,599 260.44 2,499,963
2013-05-07 REGN Sale 100,000 262.88 26,288,000
2013-05-06 REGN Option Ex 192,308 13.00 2,500,004
2012-12-19 REGN Option Ex 50,846 15.53 789,536
2012-12-17 REGN Option Ex 10,369 109.29 1,133,228
2012-05-01 REGN Sale 33,165 134.59 4,463,776
2012-03-26 REGN Sale 33,150 120.65 3,999,547
2012-02-15 REGN Option Ex 133,332 8.50 1,133,322
2012-01-05 REGN Sale 27,713 58.00 1,607,354
2011-12-01 REGN Sale 27,713 59.16 1,639,362
2011-11-30 REGN Option Ex 200,000 28.01 5,602,000
2009-12-03 REGN Option Ex 100,000 8.77 877,000
2008-12-16 REGN Option Ex 100,000 7.41 741,000
2008-12-16 REGN Sale 26,991 16.40 442,652
2007-04-16 REGN Sale 400 24.99 9,997
2007-04-13 REGN Option Ex 90,444 10.56 955,359
2007-04-16 REGN Sale 30,883 24.58 759,011
2007-04-09 REGN Option Ex 9,556 10.56 100,940
2007-04-09 REGN Sale 9,556 23.83 227,738
2006-01-09 REGN Sale 900 17.24 15,512
2005-12-27 REGN Option Ex 25,000 12.75 318,750
2005-12-27 REGN Sale 5,500 14.87 81,801

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yancopoulos George (Bd. Co-Chair, President & CSO of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.